Downregulation of EPHX2 may promote malignant behaviors of tumor cells by affecting lipid signaling pathways, such as the phosphatidylinositol-3-kinase (PI3K)/protein kinase B (AKT) signaling pathway. Here, AKT1 is linked to neoplasm.